Cancer stem cells in drug resistance: an introduction to the e-book covering the special issue on the “Cancer Stem Cells and Drug Resistance”

Balázs Sarkadi

Cancer Drug Resistance ›› 2023, Vol. 6 ›› Issue (2) : 239 -41.

PDF
Cancer Drug Resistance ›› 2023, Vol. 6 ›› Issue (2) :239 -41. DOI: 10.20517/cdr.2023.23
review-article

Cancer stem cells in drug resistance: an introduction to the e-book covering the special issue on the “Cancer Stem Cells and Drug Resistance”

Author information +
History +
PDF

Cite this article

Download citation ▾
Balázs Sarkadi. Cancer stem cells in drug resistance: an introduction to the e-book covering the special issue on the “Cancer Stem Cells and Drug Resistance”. Cancer Drug Resistance, 2023, 6(2): 239-41 DOI:10.20517/cdr.2023.23

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Clarke MF,Dirks PB.Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.Cancer Res2006;66:9339-44

[2]

Dick JE.Stem cell concepts renew cancer research.Blood2008;112:4793-807

[3]

Jordan CT.Cancer stem cells: controversial or just misunderstood?.Cell Stem Cell2009;4:203-5

[4]

Shackleton M,Fearon ER.Heterogeneity in cancer: cancer stem cells versus clonal evolution.Cell2009;138:822-9

[5]

Zhou BB,Damelin M,Grindley JC.Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.Nat Rev Drug Discov2009;8:806-23

[6]

Kreso A.Evolution of the cancer stem cell model.Cell Stem Cell2014;14:275-91

[7]

Sharma SV,Li B.A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.Cell2010;141:69-80 PMCID:PMC2851638

[8]

Quintana E,Foster HR.Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized.Cancer Cell2010;18:510-23 PMCID:PMC3031091

[9]

Clevers H.The cancer stem cell: premises, promises and challenges.Nat Med2011;17:313-9

[10]

Borst P.Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?.Open Biol2012;2:120066 PMCID:PMC3376736

[11]

Gupta PB,Jiang G.Identification of selective inhibitors of cancer stem cells by high-throughput screening.Cell2009;138:645-59 PMCID:PMC4892125

[12]

Safa AR.Resistance to Cell Death and Its Modulation in Cancer Stem Cells.Crit Rev Oncog2016;21:203-19 PMCID:PMC5356509

[13]

Steinbichler TB,Dudás J.Cancer stem cells and their unique role in metastatic spread.Semin Cancer Biol2020;60:148-56

[14]

Dzobo K,Ganz C,Wonkam A.Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.Cells2020;9:1896 PMCID:PMC7464860

[15]

Safa AR.Drug and apoptosis resistance in cancer stem cells: a puzzle with many pieces.Cancer Drug Resist2022;5:850-72 PMCID:PMC9771762

[16]

Hansen Q,Smit L.Characteristics of leukemic stem cells in acute leukemia and potential targeted therapies for their specific eradication.Cancer Drug Resist2022;5:344-67 PMCID:PMC9255252

[17]

Gupta G,Saravanan S.Cancer resistance to immunotherapy: What is the role of cancer stem cells?.Cancer Drug Resist2022;5:981-94 PMCID:PMC9771758

[18]

Koltai T.The complex relationship between multiple drug resistance and the tumor pH gradient: a review.Cancer Drug Resist2022;5:277-303 PMCID:PMC9255250

[19]

Kim SH,Hsieh CH.The aqueous extract of brucea javanica reduces tumorigenicity of human lung cancer tumorspheres.Cancer Drug Resist2021;4:866-80 PMCID:PMC8992453

AI Summary AI Mindmap
PDF

78

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/